• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[艾滋病中的贫血:需避免的问题。人重组促红细胞生成素在治疗HIV阳性患者中的应用]

[Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients].

作者信息

Karwacki M, Ochocka M, Kubiak W

机构信息

Klinika Hematologii i Chorób Rozrostowych Dzieci AM w Warszawie.

出版信息

Przegl Epidemiol. 1994;48(4):441-7.

PMID:7597181
Abstract

The most common hematological abnormality associated with HIV infection is anaemia. The aetiology is multifactorial and may include the HIV virus itself; the anaemia of chronic diseases (ACD); infection with other viruses, mycobacteria and fungi; medications, especially zidovudine; and even B12 deficiency. Erythropoietin insufficiency is present in all anaemic AIDS patients, probably as a result of the mechanism of ACD. The studies, performed in patients with PGL, ARC and AIDS stages of disease demonstrate that rHuEPO is safe, and in dose of 100-200 U/kg b.w. three times a week can alleviate the anemia in AIDS patients taking AZT whose baseline EPO levels are less than 500 mU/ml.

摘要

与HIV感染相关的最常见血液学异常是贫血。病因是多因素的,可能包括HIV病毒本身;慢性病贫血(ACD);感染其他病毒、分枝杆菌和真菌;药物,尤其是齐多夫定;甚至维生素B12缺乏。所有贫血的艾滋病患者均存在促红细胞生成素不足,这可能是ACD机制导致的。在患有PGL、ARC和艾滋病各疾病阶段的患者中进行的研究表明,重组人促红细胞生成素(rHuEPO)是安全的,每周三次、剂量为100 - 200 U/kg体重可缓解基线促红细胞生成素水平低于500 mU/ml且正在服用齐多夫定的艾滋病患者的贫血症状。

相似文献

1
[Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients].[艾滋病中的贫血:需避免的问题。人重组促红细胞生成素在治疗HIV阳性患者中的应用]
Przegl Epidemiol. 1994;48(4):441-7.
2
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.重组人促红细胞生成素治疗:获得性免疫缺陷综合征贫血的研究性新药方案。总体结果。
Arch Intern Med. 1993 Dec 13;153(23):2669-75.
3
Recombinant human erythropoietin for patients with AIDS treated with zidovudine.重组人促红细胞生成素用于接受齐多夫定治疗的艾滋病患者。
N Engl J Med. 1990 May 24;322(21):1488-93. doi: 10.1056/NEJM199005243222103.
4
Experience with epoetin alfa and acquired immunodeficiency syndrome anemia.
Semin Oncol. 1998 Jun;25(3 Suppl 7):64-8.
5
The use of recombinant human erythropoietin (rHuEpo) in humans.
Cancer Surv. 1990;9(1):157-67.
6
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.重组人促红细胞生成素治疗癌症及化疗所致贫血:双盲及开放标签随访研究结果
Semin Oncol. 1994 Apr;21(2 Suppl 3):21-8.
7
[Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].[重组人促红细胞生成素治疗与淋巴增殖性疾病相关的贫血——慢性淋巴细胞增多症和多发性骨髓瘤]
Vnitr Lek. 1996 Apr;42(4):262-7.
8
Erythropoietin: mechanisms of action and indications for treatment.促红细胞生成素:作用机制与治疗指征
Neth J Med. 1993 Jun;42(5-6):187-202.
9
Erythropoietin and chronic lymphocytic leukemia.促红细胞生成素与慢性淋巴细胞白血病
Rev Clin Exp Hematol. 2002;Suppl 1:21-31.
10
Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.重组人促红细胞生成素治疗与人类免疫缺陷病毒(HIV)感染及齐多夫定治疗相关的贫血。四项临床试验综述。
Ann Intern Med. 1992 Nov 1;117(9):739-48. doi: 10.7326/0003-4819-117-9-739.